CD274 and cancer: The potential correlation of PD-L1 expression with clinical outcome—in terms of biochemical recurrence-free survival (BCRFS), metastasis-free survival (MFS), cancer-specific survival (CSS), disease-free survival (DFS), and clinical failure-free survival (CFFS)—was rarely investigated, reporting conflicting results: